This protocol covers thromboembolism of the lower limb arteries in patients who have an established indication for anticoagulation and are undergoing endovascular recanalization of the affected arteries, in the absence of high bleeding risk.
The approach involves continuing full-dose anticoagulation, with consideration of adding an antiplatelet agent alongside it for a defined period.
DOI: 10.3389/fcvm.2021.773214
In patients with an established indication for anticoagulation undergoing endovascular PAD recanalization, European guidelines recommend consideration of a 1-12 month course of aspirin or clopidogrel as addition to the anticoagulant in the absence of high bleeding risk.